BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
Fuji
Deloitte
Chinese Patent Office
Daiichi Sankyo
Argus Health
Fish and Richardson
Federal Trade Commission
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071199

« Back to Dashboard

NDA 071199 describes LEUCOVORIN CALCIUM, which is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Barr, Epic Pharma Llc, Idt Australia Ltd, Par Pharm, Xanodyne Pharm, Fresenius Kabi Usa, Luitpold, Mylan Labs Ltd, and Sagent Pharms, and is included in forty-one NDAs. It is available from seven suppliers. Additional details are available on the LEUCOVORIN CALCIUM profile page.

The generic ingredient in LEUCOVORIN CALCIUM is leucovorin calcium. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 071199
Tradename:LEUCOVORIN CALCIUM
Applicant:Barr
Ingredient:leucovorin calcium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 071199
Medical Subject Heading (MeSH) Categories for 071199
Suppliers and Packaging for NDA: 071199
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 071199 ANDA Teva Pharmaceuticals USA, Inc. 0555-0485 0555-0485-27 25 TABLET in 1 BOTTLE (0555-0485-27)
LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 071199 ANDA Teva Pharmaceuticals USA, Inc. 0555-0485 0555-0485-04 500 TABLET in 1 BOTTLE (0555-0485-04)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 25MG BASE
Approval Date:Sep 24, 1987TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Deloitte
US Army
Cerilliant
Cantor Fitzgerald
AstraZeneca
Accenture
Dow
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot